Population Analysis of Adverse Events in Different Age Groups Using Big Clinical Trials Data.

The results show that there is a significant adverse event variance at the population level between different age groups in clinical trials. The data suggest that age-associated adverse events should be considered in planning, monitoring, and regulating clinical trials.